Company / Interest Expense per Share
BioXcel Therapeutics, Inc. Interest Expense per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$4.94
FY2025
5-year range
$0.00 / $6.38
FY2022-FY2025
Trend
-22.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $0.29 to $4.94 over the past 2 years.
Based on SEC 10-K filings.
4.94 in FY2025.
Increased from $0.29 to $4.94 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, interest expense per share decreased 22.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -17.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.94 | -22.6% |
| FY2024 | $6.38 | +2087.2% |
| FY2023 | $0.29 | +20310.7% |
| FY2022 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026